These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34490046)

  • 41. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 43. A Novel Risk Model for lncRNAs Associated with Oxidative Stress Predicts Prognosis of Bladder Cancer.
    Feng L; Yang K; Kuang Q; Peng M; Li L; Luo P
    J Oncol; 2022; 2022():8408328. PubMed ID: 36268283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients.
    Qu J; Tao D; Huang W; Lu L; Fan J; Zhang S; Huang F
    Heliyon; 2023 Aug; 9(8):e18493. PubMed ID: 37520979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
    Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel risk score model based on glycolysis-related genes and a prognostic model for predicting overall survival of osteosarcoma patients.
    Chen W; Lin Y; Huang J; Yan Z; Cao H
    J Orthop Res; 2022 Oct; 40(10):2372-2381. PubMed ID: 34997639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Glycolysis-Based Long Non-coding RNA Signature Accurately Predicts Prognosis in Renal Carcinoma Patients.
    Cao H; Tong H; Zhu J; Xie C; Qin Z; Li T; Liu X; He W
    Front Genet; 2021; 12():638980. PubMed ID: 33868376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients.
    Zou J; Gu Y; Zhu Q; Li X; Qin L
    Cancer Biomark; 2022; 34(3):393-401. PubMed ID: 35068448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 53. A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer.
    Xu QT; Wang ZW; Cai MY; Wei JF; Ding Q
    Front Pharmacol; 2022; 13():1115608. PubMed ID: 36699089
    [No Abstract]   [Full Text] [Related]  

  • 54. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
    Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
    DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients.
    Wang Y; Zhou W; Ma S; Guan X; Zhang D; Peng J; Wang X; Yuan L; Li P; Mao B; Kang P; Li D; Zhang C; Jia W
    Front Oncol; 2020; 10():597877. PubMed ID: 33614485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer.
    Wang Y; Du L; Yang X; Li J; Li P; Zhao Y; Duan W; Chen Y; Wang Y; Mao H; Wang C
    Aging (Albany NY); 2020 Feb; 12(3):2857-2879. PubMed ID: 32047140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma.
    Mou Z; Yang C; Zhang Z; Wu S; Xu C; Cheng Z; Dai X; Chen X; Ou Y; Jiang H
    Front Genet; 2020; 11():566918. PubMed ID: 33424916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analyses.
    Xu X; Zhou S; Tao Y; Zhong Z; Shao Y; Yi Y
    Cell Div; 2023 Jun; 18(1):10. PubMed ID: 37355624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer.
    Li Z; Zheng J; Feng Y; Li Y; Liang Y; Liu Y; Wang X; Yang Q
    Cancer Med; 2021 Nov; 10(21):7877-7892. PubMed ID: 34581026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.